COYACoya Therapeutics, Inc.同业对比
Coya Therapeutics, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COYA本股 | $107M#8 | — | 2.2x#4 | 13.5x#3 | 123.6%#2 | -42.6%#9 | -283.9%#2 | -43.3%#3 | — | — | -27.8%#6 | — |
| GNLX | $126M#2 | — | 5.5x#8 | 15806.2x#7 | 0.0%#4 | -7.6%#7 | -415175.0%#6 | -140.2%#7 | -228.3%#3 | — | -19.0%#3 | — |
| ERNA | $5M#12 | 0.1x#1 | 0.7x#2 | 8.6x#2 | 755.9%#1 | 68.4%#2 | -1601.2%#4 | -205.3%#8 | -203.6%#2 | — | -88.7%#9 | — |
| PMN | $122M#3 | — | 2.0x#3 | — | — | -1529.3%#12 | — | -65.4%#4 | — | — | -23.2%#5 | — |
| CPIX | $117M#4 | — | 5.4x#7 | 2.6x#1 | 17.6%#3 | 56.2%#3 | -6.3%#1 | -13.1%#2 | — | — | 95.9%#1 | — |
| ANIX | $117M#5 | — | 8.1x#9 | 555.7x#5 | 0.0%#4 | 13.0%#6 | -5571.9%#5 | -75.5%#5 | -87.5%#1 | — | 7.9%#2 | — |
| CNTN | $134M#1 | — | 0.3x#1 | — | — | -194.5%#11 | — | -7.6%#1 | — | — | — | — |
| LNAI | $108M#7 | 1.5x#2 | — | 3309.7x#6 | -47.8%#6 | -101.3%#10 | -576678.5%#7 | — | — | — | -85.6%#8 | — |
| PLYX | $105M#9 | — | 42.1x#10 | — | — | 70.4%#1 | — | -361.1%#10 | — | — | — | — |
| NRXP | $111M#6 | — | — | 90.4x#4 | — | -13.9%#8 | -1324.4%#3 | — | — | — | — | — |
| ALDX | $93M#10 | — | 2.2x#5 | — | — | 39.4%#5 | — | -80.3%#6 | — | — | -69.5%#7 | — |
| BMEA | $91M#11 | — | 4.9x#6 | — | — | 55.4%#4 | — | -330.1%#9 | — | — | -21.5%#4 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-08-04。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议